Business Context and Reporting Period
This Form 8-K was filed by Inpixon (trading symbol: INPX) on October 10, 2019. The registrant is incorporated in Nevada and its common stock is listed on the Nasdaq Capital Market. The filing primarily reports the entry into a material definitive agreement regarding an equity distribution program and the waiver of certain lock-up restrictions.
Key Financial Metrics and Capital Structure
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or operating margins. The financial details disclosed are limited to the terms of the new financing arrangement and associated fees:
- Proposed Offering Size: Up to $6.5 million in aggregate offering price.
- Underwriting Commission: 4.5% of the gross sales price per share sold.
- Lock-up Waiver Fees: $65,000 payable to Ladenburg Thalmann & Co. Inc. on October 8, 2019, and $50,000 payable on October 23, 2019.
- Debt and Liquidity: The filing text does not provide specific values for current debt levels or liquidity positions.
Material Changes and Agreements
The primary material change reported is the execution of an Equity Distribution Agreement with Maxim Group LLC on October 10, 2019. Key terms include:
- At-the-Market Offering: The company may sell shares from time to time through Maxim acting as a sales agent.
- Use of Proceeds: Net proceeds are intended primarily for working capital and general corporate purposes. A portion may be used for acquisitions or investments in complementary technologies, though no specific plans or commitments exist as of the report date.
- Lock-up Waivers: The company entered into agreements to waive the 90-day lock-up period for shares held by Ladenburg Thalmann & Co. Inc. and Maxim, which were originally established following an underwriting agreement on August 12, 2019.
Outlook, Risks, and Management Commentary
Management indicated that the company is not obligated to sell any shares under the new agreement, and no assurance is given regarding the price, amount, or timing of any sales. The agreement will terminate upon the sale of $6.5 million in shares or upon 15 days' written notice by either party. The filing includes standard forward-looking statement disclaimers, noting that actual results may differ materially due to known and unknown risks. No specific operational guidance or earnings outlook was provided in this report.
Investor Verification Checklist
- Verify the current share price and trading volume on the Nasdaq Capital Market to assess the potential dilution impact of the $6.5 million offering.
- Review the company's most recent 10-Q or 10-K to determine current cash balances and working capital needs, as this filing does not disclose liquidity figures.
- Confirm the total number of shares authorized under the existing Form S-3 registration statement (File No. 333-223960) to understand the remaining capacity for future issuances.
- Monitor future filings for actual sales activity under the "at-the-market" program, as the agreement does not guarantee any sales will occur.